Comparing two budesonide pills for microscopic colitis
Part of Digestive system clinical trials.
This trial compares two different forms of the drug budesonide (a steroid that reduces inflammation in the gut) to see which works better for easing diarrhea and other symptoms of microscopic colitis. If you have microscopic colitis and are experiencing symptoms, this study could help you find an effective treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have been diagnosed with microscopic colitis (confirmed by biopsy) and have active symptoms like watery diarrhea
- If you are female and could become pregnant, you must use reliable birth control and have a negative pregnancy test
- You have not had surgery to remove part or all of your colon
- You have not taken budesonide for more than 7 days before, and you have not used other certain medications within the past 8 weeks
- You do not have other serious health conditions that could interfere with the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medication (SAR444336) can help adults with microscopic colitis stay in remission longer. It may be an option if you are already taking budesonide and have had flares in the past 8 months.
This trial studies whether budesonide extended-release tablets are safe and effective for improving symptoms in children ages 5–17 with active, mild to moderate ulcerative colitis. It also measures how the medicine moves through the body.
This study tests a rectal foam (a foam you insert into the rectum) containing budesonide, a steroid that reduces inflammation, for children and teens aged 5–17 with mild to moderate ulcerative colitis in the lower colon. It aims to find the best dose that is safe and effective.
This study tests an investigational drug for people with active mild-to-moderate ulcerative colitis. It aims to see if the drug can improve symptoms without needing advanced treatments like biologics.
This study tests an investigational pill for people with moderate-to-severe ulcerative colitis that has not improved with standard treatments. The goal is to see if the pill can reduce symptoms like bloody stools and frequent bowel movements.
This study tests an investigational drug called MB-001 for people with moderate to severe ulcerative colitis who have already tried standard treatments without success. It aims to see if the drug is safe and helps control inflammation.
Hear when a new Microscopic Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.